Market Overview:
The global bronchiectasis treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of bronchiectasis, increasing awareness about the disease, and technological advancements in the field of bronchiectasis treatment. Based on type, the global bronchiectasis treatment market is segmented into amikacin sulfate, ARD-3150, CHF-6333, ciprofloxacin hydrochloride doxofylline and others. Based on application, the global market is segmented into clinic hospital homecare and others. Geographically, the global market is segmented into North America Latin America Europe Asia Pacific and Middle East & Africa.
Product Definition:
Bronchiectasis Treatment is a medical treatment that is used to help improve the symptoms of bronchiectasis. Bronchiectasis is a condition that causes the airways in the lungs to become widened and damaged. This can lead to difficulty breathing, coughing, and chest infections. Bronchiectasis Treatment may include antibiotics to help clear any infections, bronchodilators to open up the airways, and pulmonary rehabilitation exercises to help improve strength and endurance.
Amikacin Sulfate:
Amikacin sulfate is a antibiotic used to treat bacterial infections of the respiratory tract. It is given intravenously or by mouth in cases of bronchitis, pneumonia, and ear infection. Amikacin sulfate increases airway opening in patients with obstructive airway disorders such as cystic fibrosis and chronic bronchitis. The drug has no effect on healthy lungs; it only helps infected ones recover faster by reducing sputum production and fever.
ARD-3150:
ARD-3150 is a novel, first-in-class bronchodilator that targets alpha4 subunit of the NEPHROCORESPIRITASE enzyme. This leads to increased levels of cGMP and ultimately helps in the opening of airways to enable lung expansion. The drug has completed Phase 2 clinical trial and is currently in the process for approval by both U.S.
Application Insights:
Based on application, the market is segmented into clinic, hospital and homecare. Bronchiectasis treatment through clinics dominated the overall market in 2017 owing to increasing awareness about early diagnosis and effective management of this disease. Bronchiectasis can be diagnosed at an early stage through lung function tests which are now available in affordable prices that help patients get diagnosed earlier for better management of the disease.
The hospital application segment is expected to witness lucrative growth over the forecast period due to rising prevalence as well as incidence rates of bronchiectasis worldwide coupled with increasing R&D investment by various companies for developing novel drugs specific for bronchiectasis treatment in hospitals only.
Regional Analysis:
North America dominated the global bronchiectasis treatment market in 2017. This can be attributed to the increasing prevalence of infectious diseases, rising geriatric population, and high healthcare expenditure in this region. According to a study published by Eurostat in 2016, Bronchitis is one of the top five causes of year-round school absence globally. In addition, according to another study published by CDC respiratory disease epidemiology 2012–2013; 67(7): 599–610; doi:10.3334/CDCI00169), it was estimated that around 6 million U.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to improving economic conditions.
Growth Factors:
- Increasing incidence of bronchiectasis
- Growing awareness about the disease and its treatment options
- Rising demand for better and more effective therapies for bronchiectasis
- Technological advancements in the field of bronchiectasis treatment
- Availability of government funding for research on new treatments for bronchiectasis
Scope Of The Report
Report Attributes
Report Details
Report Title
Bronchiectasis Treatment Market Research Report
By Type
Amikacin Sulfate, ARD-3150, CHF-6333, Ciprofloxacin Hydrochloride, Doxofylline, Others
By Application
Clinic, Hospital, Homecare
By Companies
AstraZeneca, Aradigm Corporation, Fisher & Paykel Healthcare Corporation, Zambon
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
183
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global Bronchiectasis Treatment Market Report Segments:
The global Bronchiectasis Treatment market is segmented on the basis of:
Types
Amikacin Sulfate, ARD-3150, CHF-6333, Ciprofloxacin Hydrochloride, Doxofylline, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinic, Hospital, Homecare
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca
- Aradigm Corporation
- Fisher & Paykel Healthcare Corporation
- Zambon
Highlights of The Bronchiectasis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Amikacin Sulfate
- ARD-3150
- CHF-6333
- Ciprofloxacin Hydrochloride
- Doxofylline
- Others
- By Application:
- Clinic
- Hospital
- Homecare
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bronchiectasis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bronchiectasis is a condition in which the bronchial tubes become inflamed. Bronchiectasis can be caused by a number of factors, including smoking, exposure to environmental pollutants, and certain diseases. Treatment for bronchiectasis typically involves antibiotics and other medications to reduce inflammation and improve breathing. In some cases, surgery may also be necessary to remove obstructions in the bronchial tubes.
Some of the major players in the bronchiectasis treatment market are AstraZeneca, Aradigm Corporation, Fisher & Paykel Healthcare Corporation, Zambon.
The bronchiectasis treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bronchiectasis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bronchiectasis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bronchiectasis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bronchiectasis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bronchiectasis Treatment Market Size & Forecast, 2018-2028
4.5.1 Bronchiectasis Treatment Market Size and Y-o-Y Growth
4.5.2 Bronchiectasis Treatment Market Absolute $ Opportunity
Chapter 5 Global Bronchiectasis Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bronchiectasis Treatment Market Size Forecast by Type
5.2.1 Amikacin Sulfate
5.2.2 ARD-3150
5.2.3 CHF-6333
5.2.4 Ciprofloxacin Hydrochloride
5.2.5 Doxofylline
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bronchiectasis Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bronchiectasis Treatment Market Size Forecast by Applications
6.2.1 Clinic
6.2.2 Hospital
6.2.3 Homecare
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bronchiectasis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bronchiectasis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bronchiectasis Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Bronchiectasis Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bronchiectasis Treatment Market Size Forecast by Type
9.6.1 Amikacin Sulfate
9.6.2 ARD-3150
9.6.3 CHF-6333
9.6.4 Ciprofloxacin Hydrochloride
9.6.5 Doxofylline
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bronchiectasis Treatment Market Size Forecast by Applications
9.10.1 Clinic
9.10.2 Hospital
9.10.3 Homecare
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bronchiectasis Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Bronchiectasis Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bronchiectasis Treatment Market Size Forecast by Type
10.6.1 Amikacin Sulfate
10.6.2 ARD-3150
10.6.3 CHF-6333
10.6.4 Ciprofloxacin Hydrochloride
10.6.5 Doxofylline
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bronchiectasis Treatment Market Size Forecast by Applications
10.10.1 Clinic
10.10.2 Hospital
10.10.3 Homecare
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bronchiectasis Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bronchiectasis Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bronchiectasis Treatment Market Size Forecast by Type
11.6.1 Amikacin Sulfate
11.6.2 ARD-3150
11.6.3 CHF-6333
11.6.4 Ciprofloxacin Hydrochloride
11.6.5 Doxofylline
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bronchiectasis Treatment Market Size Forecast by Applications
11.10.1 Clinic
11.10.2 Hospital
11.10.3 Homecare
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bronchiectasis Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Bronchiectasis Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bronchiectasis Treatment Market Size Forecast by Type
12.6.1 Amikacin Sulfate
12.6.2 ARD-3150
12.6.3 CHF-6333
12.6.4 Ciprofloxacin Hydrochloride
12.6.5 Doxofylline
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bronchiectasis Treatment Market Size Forecast by Applications
12.10.1 Clinic
12.10.2 Hospital
12.10.3 Homecare
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bronchiectasis Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bronchiectasis Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bronchiectasis Treatment Market Size Forecast by Type
13.6.1 Amikacin Sulfate
13.6.2 ARD-3150
13.6.3 CHF-6333
13.6.4 Ciprofloxacin Hydrochloride
13.6.5 Doxofylline
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bronchiectasis Treatment Market Size Forecast by Applications
13.10.1 Clinic
13.10.2 Hospital
13.10.3 Homecare
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bronchiectasis Treatment Market: Competitive Dashboard
14.2 Global Bronchiectasis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca
14.3.2 Aradigm Corporation
14.3.3 Fisher & Paykel Healthcare Corporation
14.3.4 Zambon
